
United Kingdom · Biotechnology startup
ONI, officially known as Oni Bio, is a biotechnology company based in Oxford, UK, with an operational site in San Diego, California.
Funding reportedLast round: Series B
ONI, officially known as Oni Bio, is a biotechnology company based in Oxford, UK, with an operational site in San Diego, California.
Founded in February 2016 as a spin-out from the University of Oxford, ONI specializes in super-resolution microscopy and single-molecule imaging technologies. The company aims to democratize access to advanced microscopy, allowing researchers to visualize microscopic details of life with high precision. ONI offers a range of services, including super-resolution microscopy solutions, single-molecule imaging, and real-time biological insights. Their flagship products, the Nanoimager and Aplo Scope, provide researchers with powerful tools for studying molecular interactions, protein dynamics, and drug delivery. The company supports various customer segments, including academic institutions, pharmaceutical companies, and clinical research centers, facilitating advancements in drug discovery and healthcare outcomes.
Funding, as reported
From ONI's own website: 6 on the team.
What they build
Known for
codihealth carequantitative imagingfixed cell imagingmolecular diagnosticshilo imagingstructural heterogeneitysinglemolecule fretformulation screeningtirf microscopyspectral discriminationlnp characterizationimmuno-oncology diagnosticssuper-resolution softwaresingle-molecule imagingdrug delivery
Built with from their website
AdobeAmazon SESGoogle Tag ManagerCross Pixel MediaWordPress.orgAtlassianPWALeveri-motorFont Awesome
C/C++C++GitHubMailChimpViewport MetaFishbowlLiDARZencoder
Add your raise, your deck and your story, and put ONI in front of investors. Or tell us what we have wrong.